SCHEMBL6322652

SCHEMBL6322652

CCOc1ccc(Cc2c(C)[nH]c3ccc(C(=O)O)cc23)c(Cl)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.61
PTPN5 P54829 1/20 0.59
KDM4E B2RXH2 8/20 0.48
PSMD14 O00487 1/20 0.48
RECQL P46063 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
MAPT P10636 2/20 0.47
TP53 P04637 1/20 0.47
HPGD P15428 5/20 0.46
ALDH1A1 P00352 4/20 0.46
THRB P10828 1/20 0.46
HSD17B10 Q99714 5/20 0.46
APEX1 P27695 1/20 0.46
AKR1C2 P52895 1/20 0.43
HCRTR1 O43613 1/20 0.42
MCL1 Q07820 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
PPARG P37231 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6325133 0.90 POLB (0.49) POLBPTPN5KDM4EMAPTTP53
SCHEMBL6325273 0.88 PTPN5 (0.58) POLBPTPN5KDM4EPSMD14RECQL
SCHEMBL6319268 0.85 PTPN5 (0.52) POLBPTPN5KDM4EPSMD14RECQL
SCHEMBL5881620 0.85 PTPN5 (0.57) POLBPTPN5KDM4EPSMD14RECQL
SCHEMBL6321393 0.83 POLB (0.46) POLBPTPN5KDM4EMAPTTP53
SCHEMBL5881650 0.83 PTPN5 (0.55) POLBPTPN5KDM4EPSMD14RECQL
SCHEMBL6326442 0.83 PTPN5 (0.55) POLBPTPN5KDM4EPSMD14RECQL
SCHEMBL6319864 0.82 PTPN5 (0.58) POLBPTPN5KDM4EPSMD14RECQL
SCHEMBL6319106 0.82 MAPT (0.45) POLBPTPN5MAPTTP53HPGD
SCHEMBL6134732 0.81 MAPT (0.44) POLBPTPN5KDM4EMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050171185-A1 Indole derivatives FUJISAWA PHARMACEUTICAL CO., LTD., A JAPANESE CORPORATION 2005-08-04 US disclosed
CN-1150167-C Indole derivatives ����ҩƷ��ҵ��ʽ���� 2004-05-19 CN disclosed
CN-1303371-A Indole derivatives FUJISAWA PHARMACEUTICAL CO (JP) 2001-07-11 CN disclosed
EP-1070705-A1 INDOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-01-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171185-A1 Indole derivatives PDE5A, IGFBP5, HTR5A POLB 3673/4885PTPN5 108/4885KDM4E 942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.